Global Interventional Oncology Market by Procedure (Ablation, Particle Embolization, Radiation Therapy), Cancer Type (Bone Metastasis, Breast Cancer, Kidney Cancer), End-Users - Forecast 2024-2030- Product Image

Sale

Global Interventional Oncology Market by Procedure (Ablation, Particle Embolization, Radiation Therapy), Cancer Type (Bone Metastasis, Breast Cancer, Kidney Cancer), End-Users - Forecast 2024-2030

Report
196 Pages
March 2024
Region: Global
360iResearch™
ID: 4905026

UP TO €846EUR$875USD£717GBP OFF until Dec 31^st 2024

The Interventional Oncology Market size was estimated at USD 5.04 billion in 2023, USD 5.43 billion in 2024, and is expected to grow at a CAGR of 7.86% to reach USD 8.56 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Interventional Oncology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Interventional Oncology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Interventional Oncology Market, highlighting leading vendors and their innovative profiles. These include Angiodynamics, Atricure, BALT Group, Boston Scientific Ltd., Cook Medical, Eckert & Ziegler BEBIG AG, Integer Holding Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merit Medical, Profound Medical, Siemens Healthineers AG, Sonablate Corp, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Interventional Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

Procedure
- Ablation
- Particle Embolization
- Radiation Therapy
Cancer Type
- Bone Metastasis
- Breast Cancer
- Kidney Cancer
- Liver Cancer
- Lung Cancer
- Prostate Cancer
End-Users
- Ambulatory Surgery Centers
- Hospitals
- Research & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Interventional Oncology Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Interventional Oncology Market?
What are the technology trends and regulatory frameworks in the Interventional Oncology Market?
What is the market share of the leading vendors in the Interventional Oncology Market?
Which modes and strategic moves are suitable for entering the Interventional Oncology Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Interventional Oncology Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in incidence of cancer across the globe and surge in geriatric population
5.1.1.2. Increase in government expenditures for interventional oncology
5.1.1.3. Preference for minimally invasive procedures
5.1.2. Restraints
5.1.2.1. Shortage of trained interventional oncologists
5.1.3. Opportunities
5.1.3.1. Benefits of providing interventional oncology in an outpatient setting
5.1.3.2. New technological advancements for interventional oncology
5.1.4. Challenges
5.1.4.1. Presence of alternative therapies
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Interventional Oncology Market, by Procedure

6.1. Introduction
6.2. Ablation
6.3. Particle Embolization
6.4. Radiation Therapy

7. Interventional Oncology Market, by Cancer Type

7.1. Introduction
7.2. Bone Metastasis
7.3. Breast Cancer
7.4. Kidney Cancer
7.5. Liver Cancer
7.6. Lung Cancer
7.7. Prostate Cancer

8. Interventional Oncology Market, by End-Users

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals
8.4. Research & Academic Institutes

9. Americas Interventional Oncology Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Interventional Oncology Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Interventional Oncology Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Angiodynamics
13.1.2. Atricure
13.1.3. BALT Group
13.1.4. Boston Scientific Ltd.
13.1.5. Cook Medical
13.1.6. Eckert & Ziegler BEBIG AG
13.1.7. Integer Holding Corporation
13.1.8. Johnson & Johnson Services, Inc.
13.1.9. Medtronic PLC
13.1.10. Merit Medical
13.1.11. Profound Medical
13.1.12. Siemens Healthineers AG
13.1.13. Sonablate Corp
13.1.14. Stryker Corporation
13.1.15. Terumo Corporation
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2023 VS 2030
FIGURE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INTERVENTIONAL ONCOLOGY MARKET DYNAMICS
FIGURE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2030 (%)
FIGURE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 6. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PARTICLE EMBOLIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 10. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BONE METASTASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 17. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 30. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 31. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 32. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 33. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 47. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 48. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 49. CHINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 50. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 51. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 56. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 74. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 87. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 90. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 93. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 102. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 103. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 104. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 111. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 114. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 115. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 116. POLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 117. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 118. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 119. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 129. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 138. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 147. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 148. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 149. INTERVENTIONAL ONCOLOGY MARKET LICENSE & PRICING

Companies Mentioned

Angiodynamics
Atricure
BALT Group
Boston Scientific Ltd.
Cook Medical
Eckert & Ziegler BEBIG AG
Integer Holding Corporation
Johnson & Johnson Services, Inc.
Medtronic PLC
Merit Medical
Profound Medical
Siemens Healthineers AG
Sonablate Corp
Stryker Corporation
Terumo Corporation

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	196
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.43 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.56 Billion
Compound Annual Growth Rate	7.8%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3263EUR$3,374USD£2,763GBP €3625EUR$3,749USD£3,070GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4133EUR$4,274USD£3,500GBP €4593EUR$4,749USD£3,889GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5004EUR$5,174USD£4,238GBP €5560EUR$5,749USD£4,708GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5874EUR$6,074USD£4,975GBP €6527EUR$6,749USD£5,527GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7615EUR$7,874USD£6,449GBP €8461EUR$8,749USD£7,165GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Interventional Oncology Devices Global Market Report 2024

Global Interventional Oncology Market Analysis & Forecast to 2024-2034

Interventional Oncology Devices - Global Strategic Business Report

Global Interventional Oncology Market 2024-2028

Global Next-Generation Oncology Devices & Solutions Market by Component (Devices, Software), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End User - Forecast 2024-2030

About the Interventional Oncology Market